Jason Green, DO
Dermatology · Fort Lauderdale, FLNPI 1427167261
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (39.3%), speaking fees and other — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Convatec Inc. at 27.0% of the total. 2025 is the largest year on record at $103,916, 4.1 times the $25,610 reported in 2019. Among dermatology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 717 payments — averaging $297.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$58K
- LEO Pharma Inc.$50K
- E.r. Squibb & Sons, L.L.C.$23K
- Galderma Laboratories, L.p.$17K
- Bristol Myers Squibb$15K
- Almirall LLC$11K
- plus $40K from 31 others
Across 21 payments — averaging $11,935 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$185K
- GSK$66K
What the payments were for
- Consulting fees$83,83439%
- Speaking & faculty fees$78,26137%
- Travel & lodging$5,3703%
- Food & beverage$14,9837%
- Education$4350%
- Other$30,20014%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$56,743
- ADBRY$43,438
- Otezla$22,289
- NEMLUVIO$16,365
- Seysara$10,194
- ANZUPGO$9,565
- Neo-Synalar$9,350
- DUPIXENT$3,170
- Tovet (emollient formulation)$2,800
- Ketodan$1,900
- Genadur$1,400
- Klisyri$800
- Kerecis SurgiClose$643
- AMELUZ$475
- BF-RhodoLED$475
- XEPI$475
- Clodan$350
- CIBINQO$220
- Sotyktu$213
- Kerecis GraftGuide$161
How this compares
$213,083 in reported general payments places this provider in the 95th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 49 | $182,369 |
| Clobetasol Propionate | 123 | $5,320 |
| Ketoconazole | 239 | $4,661 |
| Triamcinolone Acetonide | 160 | $2,216 |
| Metronidazole | 30 | $2,034 |
| Tacrolimus | 12 | $1,989 |
| Fluorouracil | 26 | $1,785 |
| Clindamycin Phosphate | 52 | $1,679 |
| Doxycycline Hyclate | 140 | $1,539 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 35 | $792 |
| ValacyclovirValacyclovir Hcl | 49 | $722 |
| Hydrocortisone | 87 | $567 |
| Mupirocin | 63 | $539 |
| Hydroxyzine Hcl | 59 | $526 |
| SsdSilver Sulfadiazine | 14 | $349 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Fort Lauderdale
- Matthew EliasFort Lauderdale$210K
- Jerome ObedFort Lauderdale$150K
- Willie RichardsonFort Lauderdale$124K
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.